180 related articles for article (PubMed ID: 1550122)
1. Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients.
Ashton LJ; Brooks DA; McCourt PA; Muller VJ; Clements PR; Hopwood JJ
Am J Hum Genet; 1992 Apr; 50(4):787-94. PubMed ID: 1550122
[TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies.
Bunge S; Clements PR; Byers S; Kleijer WJ; Brooks DA; Hopwood JJ
Biochim Biophys Acta; 1998 Sep; 1407(3):249-56. PubMed ID: 9748610
[TBL] [Abstract][Full Text] [Related]
3. Hurler syndrome: a patient with abnormally high levels of alpha-L-iduronidase protein.
Brooks DA; Harper GS; Gibson GJ; Ashton LJ; Taylor JA; McCourt PA; Freeman C; Clements PR; Hoffmann JW; Hopwood JJ
Biochem Med Metab Biol; 1992 Jun; 47(3):211-20. PubMed ID: 1627351
[TBL] [Abstract][Full Text] [Related]
4. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
[TBL] [Abstract][Full Text] [Related]
5. Mucopolysaccharidosis type I subtypes. Presence of immunologically cross-reactive material and in vitro enhancement of the residual alpha-L-iduronidase activities.
Schuchman EH; Desnick RJ
J Clin Invest; 1988 Jan; 81(1):98-105. PubMed ID: 3121676
[TBL] [Abstract][Full Text] [Related]
6. The Hurler syndrome: detection of patients and heterozygotes using a microassay for alpha-L-iduronidase in fibroblasts.
Kleijer WJ; Hensing-Wolffers GM; Thompson EJ; Niermeijer MF
Clin Chim Acta; 1981 Oct; 116(1):47-54. PubMed ID: 6797759
[TBL] [Abstract][Full Text] [Related]
7. alpha-L-iduronidase in normal and mucopolysaccharidosis-type-I human skin fibroblasts.
Taylor JA; Gibson GJ; Brooks DA; Hopwood JJ
Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):263-8. PubMed ID: 1900419
[TBL] [Abstract][Full Text] [Related]
8. Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation.
Keeling KM; Brooks DA; Hopwood JJ; Li P; Thompson JN; Bedwell DM
Hum Mol Genet; 2001 Feb; 10(3):291-9. PubMed ID: 11159948
[TBL] [Abstract][Full Text] [Related]
9. alpha-L-Iduronidase deficiency in mucopolysaccharidosis type I against a radiolabelled sulfated disaccharide substrate derived from dermatan sulfate.
Muller VJ; Hopwood JJ
Clin Genet; 1984 Nov; 26(5):414-21. PubMed ID: 6437709
[TBL] [Abstract][Full Text] [Related]
10. Properties of alpha-L-iduronidase in cultured skin fibroblasts from alpha-L-iduronidase-deficient patients.
Fujibayashi S; Minami R; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
Hum Genet; 1984; 65(3):268-72. PubMed ID: 6421718
[TBL] [Abstract][Full Text] [Related]
11. Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.
Unger EG; Durrant J; Anson DS; Hopwood JJ
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):43-9. PubMed ID: 7998955
[TBL] [Abstract][Full Text] [Related]
12. c.1898C>G/p.Ser633Trp Mutation in Alpha-L-Iduronidase: Clinical and Structural Implications.
Peña-Gomar I; Jiménez-Mariscal JL; Cerón M; Rosas-Trigueros J; Reyes-López CA
Protein J; 2021 Feb; 40(1):68-77. PubMed ID: 33389473
[TBL] [Abstract][Full Text] [Related]
13. Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients.
Brooks DA; McCourt PA; Gibson GJ; Ashton LJ; Shutter M; Hopwood JJ
Am J Hum Genet; 1991 Apr; 48(4):710-9. PubMed ID: 1901688
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.
Perkins KJ; Muller V; Weber B; Hopwood JJ
Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012
[TBL] [Abstract][Full Text] [Related]
15. A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype.
Scott HS; Litjens T; Hopwood JJ; Morris CP
Hum Mutat; 1992; 1(2):103-8. PubMed ID: 1301196
[TBL] [Abstract][Full Text] [Related]
16. The alpha-L-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation.
Hein LK; Hopwood JJ; Clements PR; Brooks DA
Biochim Biophys Acta; 2003 Oct; 1639(2):95-103. PubMed ID: 14559116
[TBL] [Abstract][Full Text] [Related]
17. Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells.
Baldo G; Quoos Mayer F; Burin M; Carrillo-Farga J; Matte U; Giugliani R
Cells Tissues Organs; 2012; 195(4):323-9. PubMed ID: 21778683
[TBL] [Abstract][Full Text] [Related]
18. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
19. Glycosidase active site mutations in human alpha-L-iduronidase.
Brooks DA; Fabrega S; Hein LK; Parkinson EJ; Durand P; Yogalingam G; Matte U; Giugliani R; Dasvarma A; Eslahpazire J; Henrissat B; Mornon JP; Hopwood JJ; Lehn P
Glycobiology; 2001 Sep; 11(9):741-50. PubMed ID: 11555618
[TBL] [Abstract][Full Text] [Related]
20. Mucopolysaccharidosis type I: Identification and characterization of mutations affecting alpha-L-iduronidase activity.
Lee-Chen GJ; Lin SP; Chen IS; Chang JH; Yang CW; Chin YW
J Formos Med Assoc; 2002 Jun; 101(6):425-8. PubMed ID: 12189649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
